DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2Dr.Reddy's laboratories Limited
02 1Teva API India Private Ltd
03 1AX Pharmaceutical Corp
04 1Aurobindo Pharma Limited
05 1Formosa Laboratories, Inc.
06 1Hetero Drugs Limited
07 1Laurus Labs Limited
08 1MSD International GmbH
09 1MSN Pharmachem Private Limited
10 1MYLAN LABORATORIES LIMITED
11 1Macleods Pharmaceutical Limited
12 2Morepen Laboratories Limited
13 1Professional Compounding Centers of America
14 1Professional Compounding Centers of America dba PCCA
15 1Tianish Laboratories Private Limited
16 1Unichem Laboratories Limited, India
17 1Zenfold Sustainable Technologies Private Limited
18 1Zhejiang Ausun Pharmaceutical Co., Ltd.
01 7MONTELUKAST SODIUM
02 1Montelukast
03 8Montelukast Sodium
04 1Montelukast Sodium Process 1
05 1Montelukast Sodium Process 2
06 1Montelukast sodium
07 1montelukast sodium
01 1Canada
02 1China
03 12India
04 1Israel
05 1Taiwan
06 2U.S.A
07 2United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-084
Start Marketing Date : 2010-12-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
NDC Package Code : 15894-0004
Start Marketing Date : 2019-08-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-998
Start Marketing Date : 2006-12-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42385-709
Start Marketing Date : 2010-04-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 33342-603
Start Marketing Date : 2024-05-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50473-0002
Start Marketing Date : 2002-07-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50370-0003
Start Marketing Date : 2010-04-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0018
Start Marketing Date : 2014-02-19
End Marketing Date : 2026-06-01
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0347
Start Marketing Date : 2024-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 53747-079
Start Marketing Date : 2018-09-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
22
PharmaCompass offers a list of Montelukast Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Montelukast Sodium manufacturer or Montelukast Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Montelukast Sodium manufacturer or Montelukast Sodium supplier.
PharmaCompass also assists you with knowing the Montelukast Sodium API Price utilized in the formulation of products. Montelukast Sodium API Price is not always fixed or binding as the Montelukast Sodium Price is obtained through a variety of data sources. The Montelukast Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CAS-151767-02-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CAS-151767-02-1, including repackagers and relabelers. The FDA regulates CAS-151767-02-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CAS-151767-02-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CAS-151767-02-1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CAS-151767-02-1 supplier is an individual or a company that provides CAS-151767-02-1 active pharmaceutical ingredient (API) or CAS-151767-02-1 finished formulations upon request. The CAS-151767-02-1 suppliers may include CAS-151767-02-1 API manufacturers, exporters, distributors and traders.
click here to find a list of CAS-151767-02-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CAS-151767-02-1 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CAS-151767-02-1 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CAS-151767-02-1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CAS-151767-02-1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CAS-151767-02-1 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CAS-151767-02-1 suppliers with NDC on PharmaCompass.
We have 17 companies offering CAS-151767-02-1
Get in contact with the supplier of your choice:
